Top compounds associated with response to ADAMTS20


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC 0.15 0.0006
mRNA tivozanib GDSC1000 pan-cancer AAC 0.014 0.7
mRNA tivozanib CTRPv2 pan-cancer AAC 0.0014 1
mRNA tosedostat CTRPv2 pan-cancer AAC 0.22 1e-09
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.062 0.07
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.042 0.2
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.059 0.05
mRNA trifluoperazine CTRPv2 pan-cancer AAC -0.0066 0.9
mRNA triptolide CTRPv2 pan-cancer AAC 0.075 0.03
mRNA tubastatin A GDSC1000 pan-cancer AAC -0.032 0.3
Download CSV